Decision Resources Analyst Sylvia Eash, Ph.D. is available to discuss how the recent outbreak of influenza A (H1N1) virus (swine flu) could affect the sales of key antiviral drugs that are currently available in the world's major pharmaceutical markets. Dr. Eash can also discuss how the H1N1 virus (swine flu) outbreak could affect the demand for flu vaccines in the coming months.

  Dr. Eash is available to discuss:    --  Which companies currently market the most widely used antiviral drugs       in the United States and Europe   --  The most commercially successful antiviral drugs in use today and how       the sales of these agents could be affected by the recent outbreak of       H1N1 virus (swine flu)   --  Which companies are currently developing drugs and/or vaccines for the       treatment of influenza outbreaks such as H1N1 virus (swine flu)    --  The key unmet needs and challenges for pharmaceutical companies that       are developing flu vaccines   

To speak with Dr. Eash, please contact Christopher Comfort at 781-296-2597 or ccomfort@dresources.com.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:   Christopher Comfort   781-296-2597   ccomfort@dresources.com    /PRNewswire -- May 1/ 

First Call Analyst:
FCMN Contact:

SOURCE: Decision Resources

Driven by Sales of Enbrel, Remicade and Humira, spondyloarthropathies Drug Market Grew to Nearly $2 Billion in 2008

View Now